Rheumatoid arthritis-A siddha classical drug Chitthira moolathi podi ( oral administration)
Phase 2
- Conditions
- Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
- Registration Number
- CTRI/2022/02/040076
- Lead Sponsor
- Dr V Nantha prasath
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
RA factor positive
Anti ccp test positive
CRP positive
ANA test in few selected cases
Exclusion Criteria
Other joint diseases like osteoarthritis,seri negative spondylo arthritis,ankylosing spondylitis
Infectious joint diseases like Tuberculosis, chronic poly arthritis in chickengunia viral infection
Metabolic joint disease like gout
Pregnancy and lactating mother
Chronic renal and liver disease patients
People with RA factor negative
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method In during treatment or after treatment reduction the following symptoms <br/ ><br>Pains in the more then 5 joints <br/ ><br>Morning stiffness <br/ ><br>Interphalangeal joints pain <br/ ><br>RA factor range <br/ ><br>Crp range <br/ ><br>Timepoint: 45 days
- Secondary Outcome Measures
Name Time Method To evaluate the biochemical physico-chemical and phytochemical analysis of clinical trial drug <br/ ><br>To evaluate the antimicrobial activity of trial drug <br/ ><br>To evaluate the safety profile for acute and sub acute toxicity of the trial drug chitthira moolathi podi <br/ ><br>To evaluate pharmacological analysis of the clinical trial drug <br/ ><br>To evaluate Siddha parameters and modern parameters during the treatment of Uthiravatha suronitham with trial drug <br/ ><br>To evaluate the statistical analysis of the clinical trial drug Chitthira moolathi podi <br/ ><br>To evaluate the powder microscopic study and HTPLC of the trial drugTimepoint: 45 days